Consern Cosmoceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 05-07-2024
- Paid Up Capital ₹ 1.00 M
as on 05-07-2024
- Company Age 9 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -61.22%
(FY 2023)
- Profit -133.10%
(FY 2023)
- Ebitda -130.11%
(FY 2023)
- Net Worth -41.09%
(FY 2023)
- Total Assets -16.64%
(FY 2023)
About Consern Cosmoceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Seema Mahajan and Kuljive Mahajan serve as directors at the Company.
- CIN/LLPIN
U51101MH2015PTC266511
- Company No.
266511
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jul 2015
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Consern Cosmoceuticals Private Limited offer?
Consern Cosmoceuticals Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Facial Kit, Beauty Cosmetics, Bleaching Cream, Herbal Facial Kit, Fairness Facial Kit, Skin Care Cosmetics, Skin Serum, Hand Sanitizers & Personal Hygiene, Face Wash.
Who are the key members and board of directors at Consern Cosmoceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Seema Mahajan  | Managing Director | 10-Jul-2015 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kuljive Mahajan | Director | 10-Jul-2015 | Current |
Financial Performance of Consern Cosmoceuticals.
Consern Cosmoceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 61.22% decrease. The company also saw a substantial fall in profitability, with a 133.1% decrease in profit. The company's net worth observed a substantial decline by a decrease of 41.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Consern Cosmoceuticals?
In 2023, Consern Cosmoceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Consern Bharat Private LimitedActive 1 year 30 daysSeema Mahajan and Kuljive Mahajan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Consern Cosmoceuticals?
Unlock and access historical data on people associated with Consern Cosmoceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Consern Cosmoceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Consern Cosmoceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
